| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/10/2001 | WO2001032641A1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 05/10/2001 | WO2001032640A1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097158A2 Ligands for metals and metal-catalyzed processes |
| 05/09/2001 | EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 05/09/2001 | EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides |
| 05/09/2001 | CN1294127A Process for preparing piperine |
| 05/09/2001 | CN1294123A Catalytic synthesis process of asymmetric aryl substituted carbamide compounds |
| 05/08/2001 | US6229047 Dipole aligned NLO chromophores |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228889 Methods for treatment of conditions associated with lactosylceramide |
| 05/08/2001 | US6228878 Administering indolin-5-one derivatives; inhibiting formation of abnormally phosphorylated paired helical filament epitopes |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/03/2001 | WO2001030772A1 Compounds and their use as cysteine protease inhibitors |
| 05/03/2001 | WO2001030749A1 Novel compounds |
| 05/03/2001 | WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | WO2000066546A3 Monofluoroalkyl derivatives |
| 05/03/2001 | DE10033912A1 Chirale polymerisierbare Verbindungen Chiral polymerizable compounds |
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 05/02/2001 | EP1095128A1 Amine reaction compounds comprising one or more active ingredient |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP1095008A1 Method for purifying hexamethylenediamine in mixtures of hexamethylenediamine and an unsaturated cyclic imine |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094812A1 Angiogenesis inhibitors |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0882010B1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293654A Anti-tumour agents |
| 05/01/2001 | US6225487 New ligands that may be combined with or coordinated to transition metals or precursor compounds to provide useful catalysts |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225302 Amidino protease inhibitors |
| 05/01/2001 | US6224734 Plant growth regulator compositions |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 04/26/2001 | WO2001029016A1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/26/2001 | WO2001028991A1 N-cycloalkyl thiooxamide derivatives |
| 04/26/2001 | WO2001028498A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | WO2000075121A3 Process for preparing 10,11-methanobenzosuberane derivatives |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | CN1064957C N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221914 Sulfonamide bridging compounds that inhibit tryptase activity |
| 04/24/2001 | US6221871 Treating schizophrenia, depression or parkinson's disease |
| 04/24/2001 | US6221868 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
| 04/24/2001 | US6221866 Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | CA2222976C Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 04/24/2001 | CA2166203C Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]- 6-chloro-1,3-dihydro-indol-2-one |
| 04/24/2001 | CA2078520C Trimetazidine derivatives, process for preparing same and pharmaceutical compositions containing same |
| 04/22/2001 | WO2002102250A1 $g(in vivo) imaging |
| 04/22/2001 | CA2422767A1 In vivo imaging |
| 04/18/2001 | EP1092713A2 Piperidinopentanamines and their use as catalysts in the preparation of urethanes |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1091947A1 Alpha-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents |
| 04/18/2001 | EP1091737A2 Calcium channel blockers |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | EP0904265B1 Preparation of bis(fluoroalkylenesulfonyl)imides and (fluoroalkylsulfonyl) (fluorosulfonyl)imides |
| 04/18/2001 | CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide |
| 04/17/2001 | US6218576 Process for producing a diarylamine |
| 04/17/2001 | US6218536 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions |
| 04/17/2001 | US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025217A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025172A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | WO2001024786A1 Preventive or therapeutic drugs for diabetes |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385715A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | CA2372715A1 Preventive or therapeutic drugs for diabetes |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090913A1 N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1089967A1 Novel compounds useful in pain management |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | CN1291186A Cyclic amide compounds |
| 04/11/2001 | CN1291185A Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1290700A Phenyl piperazine derivatives |